Inhibition of glucose metabolism through treatment of BRAF mutated metastatic melanoma with vemurafenib.

e21005Background: Increased glucose metabolism is a hallmark of neoplastic cells that allows self-promotion of growth and survival. The enzyme 6-phosphofructo-2-kinase (PFKFB3) is an integral contr...